675 related articles for article (PubMed ID: 26864033)
41. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
Quan FS; Huang C; Compans RW; Kang SM
J Virol; 2007 Apr; 81(7):3514-24. PubMed ID: 17251294
[TBL] [Abstract][Full Text] [Related]
42. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
[TBL] [Abstract][Full Text] [Related]
43. Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus.
Kim MC; Song JM; O E; Kwon YM; Lee YJ; Compans RW; Kang SM
Mol Ther; 2013 Feb; 21(2):485-92. PubMed ID: 23247101
[TBL] [Abstract][Full Text] [Related]
44. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
[TBL] [Abstract][Full Text] [Related]
45. Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
Kim KH; Kwon YM; Lee YT; Hwang HS; Kim MC; Ko EJ; Wang BZ; Quan FS; Kang SM
Virology; 2018 Nov; 524():172-181. PubMed ID: 30199754
[TBL] [Abstract][Full Text] [Related]
46. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
[TBL] [Abstract][Full Text] [Related]
47. A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice.
Inn KS; Lee GJ; Quan FS
Immunol Invest; 2014; 43(3):236-54. PubMed ID: 24354853
[TBL] [Abstract][Full Text] [Related]
48. A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
Ramirez A; Morris S; Maucourant S; D'Ascanio I; Crescente V; Lu IN; Farinelle S; Muller CP; Whelan M; Rosenberg W
Vaccine; 2018 Feb; 36(6):873-880. PubMed ID: 29306508
[TBL] [Abstract][Full Text] [Related]
49. Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.
Lee YN; Kim MC; Lee YT; Hwang HS; Lee J; Kim C; Kang SM
PLoS One; 2015; 10(9):e0137822. PubMed ID: 26366729
[TBL] [Abstract][Full Text] [Related]
50. Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection.
Kwon JS; Yoon J; Kim YJ; Kang K; Woo S; Jung DI; Song MK; Kim EH; Kwon HI; Choi YK; Kim J; Lee J; Yoon Y; Shin EC; Youn JW
Eur J Immunol; 2014 Aug; 44(8):2360-9. PubMed ID: 24825439
[TBL] [Abstract][Full Text] [Related]
51. Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: extending the potential of broadly cross-protecting epitopes.
Wibowo N; Hughes FK; Fairmaid EJ; Lua LH; Brown LE; Middelberg AP
Vaccine; 2014 Jun; 32(29):3651-5. PubMed ID: 24795225
[TBL] [Abstract][Full Text] [Related]
52. The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells.
Day EB; Zeng W; Doherty PC; Jackson DC; Kedzierska K; Turner SJ
J Immunol; 2007 Aug; 179(4):2187-94. PubMed ID: 17675478
[TBL] [Abstract][Full Text] [Related]
53. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
[TBL] [Abstract][Full Text] [Related]
54. Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses.
Choi A; Ibañez LI; Strohmeier S; Krammer F; García-Sastre A; Schotsaert M
Front Immunol; 2020; 11():1166. PubMed ID: 32582220
[TBL] [Abstract][Full Text] [Related]
55. Annual influenza vaccination affects the development of heterosubtypic immunity.
Bodewes R; Fraaij PL; Kreijtz JH; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2012 Dec; 30(51):7407-10. PubMed ID: 22643217
[TBL] [Abstract][Full Text] [Related]
56. Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.
Szurgot I; Szolajska E; Laurin D; Lambrecht B; Chaperot L; Schoehn G; Chroboczek J
Vaccine; 2013 Sep; 31(40):4338-46. PubMed ID: 23880363
[TBL] [Abstract][Full Text] [Related]
57. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
58. Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections.
Bernasconi V; Bernocchi B; Ye L; Lê MQ; Omokanye A; Carpentier R; Schön K; Saelens X; Staeheli P; Betbeder D; Lycke N
Front Immunol; 2018; 9():2060. PubMed ID: 30271406
[TBL] [Abstract][Full Text] [Related]
59. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
[TBL] [Abstract][Full Text] [Related]
60. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
